摘要:
The present invention relates to novel cationic lipids, transfection agents, microparticles, nanoparticles, and short interfering nucleic acid (siNA) molecules. The invention also features compositions, and methods of use for the study, diagnosis, and treatment of traits, diseases and conditions that respond to the modulation of gene expression and/or activity in a subject or organism. Specifically, the invention relates to novel cationic lipids, microparticles, nanoparticles and transfection agents that effectively transfect or deliver biologically active molecules.
摘要:
The present invention relates to novel cationic lipids, transfection agents, microparticles, nanoparticles, and short interfering nucleic acid (siNA) molecules. The invention also features compositions, and methods of use for the study, diagnosis, and treatment of traits, diseases and conditions that respond to the modulation of gene expression and/or activity in a subject or organism. Specifically, the invention relates to novel cationic lipids, microparticles, nanoparticles and transfection agents that effectively transfect or deliver biologically active molecules, such as antibodies (e.g., monoclonal, chimeric, humanized etc.), cholesterol, hormones, antivirals, peptides, proteins, chemotherapeutics, small molecules, vitamins, co-factors, nucleosides, nucleotides, oligonucleotides, enzymatic nucleic acids, antisense nucleic acids, triplex forming oligonucleotides, 2,5-A chimeras, dsRNA, allozymes, aptamers, decoys and analogs thereof, and small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules, to relevant cells and/or tissues, such as in a subject or organism. Such novel cationic lipids, microparticles, nanoparticles and transfection agents are useful, for example, in providing compositions to prevent, inhibit, or treat diseases, conditions, or traits in a cell, subject or organism. The compositions described herein are generally referred to as formulated molecular compositions (FMC) or lipid nanoparticles (LNP).
摘要:
The present invention relates to novel cationic lipids, transfection agents, microparticles, nanoparticles, and short interfering nucleic acid (siNA) molecules. The invention also features compositions, and methods of use for the study, diagnosis, and treatment of traits, diseases and conditions that respond to the modulation of gene expression and/or activity in a subject or organism. Specifically, the invention relates to novel cationic lipids, microparticles, nanoparticles and transfection agents that effectively transfect or deliver biologically active molecules, such as antibodies (e.g., monoclonal, chimeric, humanized etc.), cholesterol, hormones, antivirals, peptides, proteins, chemotherapeutics, small molecules, vitamins, co-factors, nucleosides, nucleotides, oligonucleotides, enzymatic nucleic acids, antisense nucleic acids, triplex forming oligonucleotides, 2,5-A chimeras, dsRNA, allozymes, aptamers, decoys and analogs thereof, and small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), short hairpin RNA (shRNA), and RNAi inhibitor molecules, to relevant cells and/or tissues, such as in a subject or organism. Such novel cationic lipids, microparticles, nanoparticles and transfection agents are useful, for example, in providing compositions to prevent, inhibit, or treat diseases, conditions, or traits in a cell, subject or organism. The compositions described herein are generally referred to as formulated molecular compositions (FMC) or lipid nanoparticles (LNP).
摘要:
The instant invention provides for novel lipid nanoparticles and novel lipid nanoparticle components (specifically cationic lipids) that are useful for the delivery of nucleic acids, specifically siRNA, for therapeutic purposes.
摘要:
A tool bag for storing and organizing tools is provided. In general, the described tool bag includes a flat bottom surface connected to at least one side components, wherein the flat bottom surface includes a hard flat surface. The tool bag also includes a mid-section including a hard surfaced compartment with two surfaces, where the hard surfaced compartment is positioned perpendicular to the flat bottom surface and divides the tool bag's internal bag space into two substantially equal portions. Furthermore, a plurality of tool organizing apparatuses is affixed to the two surfaces of the hard surfaced compartment configured to secure and organize tools.
摘要:
Various systems, computer program products, and methods for resolving financial issues using conditional debt resolution offers are described. A method may include determining a debtor that is to receive a conditional debt resolution offer. In some implementations, the conditional debt resolution offer is subject to a condition for the conditional debt resolution offer to be valid. When valid and accepted by the debtor, the conditional debt resolution offer at least partially resolves the debt. In some implementations, the method may include causing the conditional debt resolution offer to be communicated to the debtor. In some implementations, the method may include determining whether the condition has been satisfied. In some implementations, the method may include validating the conditional debt resolution offer when the condition has been satisfied or invalidating the conditional debt resolution offer when the condition has not been satisfied.
摘要:
In various aspects, code-based indicia contain secured network access credentials. In some aspects, a computer processor receives user input that specifies secured network access credentials, and the computer processor creates or modifies credentials for establishing a secured network connection. In these aspects, the computer processor generates code-based indicia that contain at least part of the secured network access credentials. In other aspects, a computer processor scans the code-based indicia and extracts the network access credentials. In these aspects, the computer processor employs the network access credentials to establish the secured network connection. In additional aspects, a network router apparatus renders the code-based indicia to an active display. In further aspects, a network router apparatus conditions grant of network access to a device on receipt from the device of an answer to a security question included in the secured network access credentials.
摘要:
The invention discloses a human cancer-related gene, LAPTM4B, its encoded products and their applications thereof. This human cancer-related gene provided by this invention comprises one of the following nucleotide sequences: (1) SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 6, or SEQ ID No: 8 in the sequence listings; (2) SEQ ID No: 4, SEQ ID No: 5, or SEQ ID No: 7 in the sequence listings which are proteins encoded by the polynucleotides in sequences of SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3 and SEQ ID No: 6. (3) Applications of the polynucleotides and polypeptides in the listings in diagnosis and treatments of cancer. This invention enables the developments of new cancer diagnostic markers and new anti-cancer medicines. It would create a significant impact on human society.
摘要翻译:本发明公开了一种人癌相关基因LAPTM4B及其编码产物及其应用。 本发明提供的这种人类癌症相关基因包含以下核苷酸序列之一:(1)SEQ ID No:1,SEQ ID No:2,SEQ ID No:3,SEQ ID No:6或SEQ ID No: 8在序列表中; (2)序列表中SEQ ID No:4,SEQ ID No:5或SEQ ID No:7,它们是由SEQ ID No:1,SEQ ID No:2,SEQ ID No :3和SEQ ID No:6。(3)多核苷酸和多肽在癌症诊断和治疗中的应用。 本发明使得能够开发新的癌症诊断标记物和新的抗癌药物。 这将对人类社会产生重大影响。
摘要:
The invention discloses a human cancer-related gene, LAPTM4B, its encoded products and their applications thereof. This human cancer-related gene provided by this invention comprises one of the following nucleotide sequences: (1) SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 6, or SEQ ID No: 8 in the sequence listings; (2) Polynucleotides that encode the protein sequences of SEQ ID No: 4, SEQ ID No: 5, or SEQ ID No: 7 in the sequence listings; (3) DNA sequences having above 90% homology with the DNA sequences specified by SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 6, or SEQ ID No: 8 in the sequence listings, and these DNA sequences encode the proteins with the same or similar functions. This invention enables the developments of new anti-cancer approaches and new anti-cancer medicines. It would create a significant impact on human society.
摘要翻译:本发明公开了一种人癌相关基因LAPTM4B及其编码产物及其应用。 本发明提供的人类癌症相关基因包含以下核苷酸序列之一:(1)SEQ ID No:1,SEQ ID No:2,SEQ ID No:3,SEQ ID No:6或SEQ ID No: 8在序列表中; (2)编码序列表中SEQ ID No:4,SEQ ID No:5或SEQ ID No:7的蛋白质序列的多核苷酸; (3)与序列表中SEQ ID No:1,SEQ ID No:2,SEQ ID No:3,SEQ ID No:6或SEQ ID No:8指定的DNA序列具有90%以上同源性的DNA序列 ,并且这些DNA序列编码具有相同或相似功能的蛋白质。 本发明使得能够开发新的抗癌方法和新的抗癌药物。 这将对人类社会产生重大影响。
摘要:
The present invention provides a system and method for abstracting multiple network attached storage (“NAS”) locations, providing a single global namespace and a single mount point that is protocol and location-independent. As a result, rather than identifying each NAS and file server by location, access is provided through a single transparent mechanism. In order to maintain transparency, the present invention provides a way to reconcile the different naming practices for different file server protocols.